loader
Please Wait
Applying Filters...

Athena Athena

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Biophore India Pharmaceuticals Pvt Ltd

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Acitretin (1)

02 Acrivastine (1)

03 Agomelatine (1)

04 Alosetron HCl (1)

05 Aminocaproic Acid (1)

06 Aviptadil Acetate (1)

07 Belinostat (1)

08 Bempedoic Acid (1)

09 Bendamustine (1)

10 Bortezomib (1)

11 Brexpiprazole (1)

12 Calcobutrol (1)

13 Calteridol Calcium (1)

14 Cannabidiol (1)

15 Carfilzomib (1)

16 Cariprazine Hydrochloride (1)

17 Cetrorelix Acetate (1)

18 Chlorambucil (1)

19 Chlorpromazine Hydrochloride (1)

20 Chlorzoxazone (1)

21 Cladribine (1)

22 Clofarabine (1)

23 Clomipramine Hydrochloride (1)

24 Copper Sulfate (1)

25 Crisaborole (1)

26 Cysteamine Bitartrate (1)

27 Cysteamine Hydrochloride (1)

28 Cysteamine-S-phosphate (1)

29 DOTA (1)

30 Dantrolene (1)

31 Decitabine (1)

32 Diatrizoate Meglumine (1)

33 Diatrizoate Sodium (1)

34 Diazoxide (1)

35 Dichlorphenamide (1)

36 Dimethyl Fumarate (1)

37 Docosanol (1)

38 Dofetilide (1)

39 Edaravone (1)

40 Elagolix (1)

41 Eliglustat (1)

42 Ertugliflozin (1)

43 Erythromycin Lactobionate (1)

44 Ethacrynate Sodium (1)

45 Ethacrynic Acid (1)

46 Ethiodized Oil (1)

47 Favipiravir (1)

48 Fenfluramine (1)

49 Fenoprofen Calcium (1)

50 Ferric Citrate (1)

51 Fluphenazine (1)

52 Frovatriptan (1)

53 Gadobenic Acid (1)

54 Gadobutrol (1)

55 Gadolinium Dtpa (1)

56 Gadoterate Meglumine (1)

57 Gadoteridol (1)

58 Glycerol Phenylbutyrate (1)

59 Icatibant Acetate (1)

60 Indigo Carmine (1)

61 Indocyanine Green (1)

62 Iohexol (1)

63 Iron Sucrose (1)

64 Isoproterenol (1)

65 Isosulfan Blue (1)

66 Isotretinoin (1)

67 Lercanidipine (1)

68 Levothyroxine Sodium (1)

69 Liothyronine Sodium (1)

70 Manganese Sulfate (1)

71 Melphalan (1)

72 Methazolamide (1)

73 Methylene Blue (1)

74 Methyltyrosine (1)

75 Metolazone (1)

76 Mexiletine (1)

77 Molnupiravir (1)

78 Nadolol (1)

79 Naphazoline Hydrochloride (1)

80 Naphazoline Nitrate (1)

81 Nelarabine (1)

82 Nilutamide (1)

83 Nimodipine (1)

84 Nirmatrelvir (1)

85 Nitazoxanide (1)

86 Nitisinone (1)

87 Obeticholic Acid (1)

88 Palbociclib (1)

89 Penicillamine (1)

90 Pentetic Acid (1)

91 Permethrin (1)

92 Pimavanserin (1)

93 Plerixafor (1)

94 Primidone (1)

95 Procainamide (1)

96 Procainamide Hydrochloride (1)

97 Prochlorperazine (1)

98 Prochlorperazine Edisylate (1)

99 Prochlorperazine Maleate (1)

100 Prochlorperazine Mesylate (1)

101 Prucalopride Succinate (1)

102 Ramelteon (1)

103 Regadenoson Monohydrate (1)

104 Safinamide Mesylate (1)

105 Sapropterin Hydrochloride (1)

106 Selenious Acid (1)

107 Selexipag (1)

108 Sildenafil Citrate (1)

109 Sincalide (1)

110 Sodium Nitroprusside (1)

111 Sodium Thiosulfate (1)

112 Sucroferric Oxyhydroxide (1)

113 Sugammadex Sodium (1)

114 Sulfobutylether-β-Cydodextrin (SBECD) (1)

115 Tafamidis Meglumine (1)

116 Taurolidine (1)

117 Tavaborole (1)

118 Tegaserod (1)

119 Temozolomide (1)

120 Thiamine Hydrochloride (1)

121 Tiopronin (1)

122 Tipiracil Hydrochloride (1)

123 Tretinoin (1)

124 Trientine Hydrochloride (1)

125 Trifluridine (1)

126 Urapidil Hydrochloride (1)

127 Valsartan (1)

128 Vigabatrin (1)

129 Vitamin K1 (1)

130 Zileuton (1)

131 Zinc Sulphate (1)

132 Zofenopril Calcium (1)

filter

01 Biophore India Pharmaceuticals Pvt Ltd (132)

filter

01 India (132)

Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among ...
Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Post Enquiry
POST ENQUIRY